Researchers who worked at GlaxoSmithKline before leading RespiVert to a takeover by Johnson & Johnson have raised $30.4 million (£24.5 million) for their…

The FDA has rejected AstraZeneca’s hyperkalemia drug ZS-9 for the second time in 12 months. The news marks a further blow for a program AstraZeneca saw giving…

Upstart eGenesis got off a healthy $38 million Series A round today as it looks to use cutting-edge science to “solve the shortage of organs for donation” by…

Immuno-oncology startup Neon Therapeutics has teamed up with Vedantra, a vaccine delivery specialist, to try to add punch to its neoantigen vaccine pipeline.

Ex-Pfizer exec is looking for new biopharma opportunities as Intrexon spins out all its healthcare programs into a new company.

Analysts at Barclays have had enough with Gilead and taken the unusual approach of writing an open letter to the Big Biotech to help it reshape and earn back…

Cancer therapeutics biotech BeyondSpring scored $54.3 million in a combination IPO and private placement. The total falls well short of its initial $100…

Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech.

Deals